|
National Stock Number(NSN): 6505-01-301-0808 (6505013010808, 013010808)
| NIIN: |
01-301-0808 |
Item Name: |
HAEMOPHILUS B OLIGOSACCHARIDE CONJUGATE (DIPHTHERIA CRM197 PROTEIN CONJUGATE) VACCINE |
INC: |
49538
|
| FSC: |
6505
|
Assignment Date: |
May-25-1989 |
CRIT: |
N |
IIG: |
49538 |
| ISC: |
2 |
Date Standardized: |
May-25-1989 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Dec-01-2001 |
PMIC: |
A |
FIIG: |
T088-D |
| ESD: |
|
Schedule B: |
|
DEMIL: |
A |
DEMIL INT: |
|
| TIIC: |
1 |
Originator: |
KX |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
420341 |
06404
|
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV |
H |
3 |
2 |
4 |
KX |
|
|
|
|
|
|
|
9-0448 |
64616
|
DEFENSE MEDICAL STANDARDIZATION BOARD |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
HIBTITER |
06404
|
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
HIBTITER |
0CBS8
|
PRAXIS BIOLOGIES INC |
H |
5 |
1 |
|
|
|
|
|
|
|
|
|
NDC00005-0104-41 |
06404
|
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV |
H |
3 |
2 |
4 |
ZZ |
|
|
|
|
|
|
|
NDC00005-4203-41 |
06404
|
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV |
H |
5 |
2 |
|
|
|
|
|
|
|
|
|
NDC05312-4203-41 |
06404
|
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV |
H |
5 |
9 |
|
|
|
|
|
|
|
|
|
NDC53124-0104-41 |
06404
|
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV |
H |
5 |
9 |
4 |
KX |
|
|
|
|
|
|
|
NDC53124-0203-41 |
0CBS8
|
PRAXIS BIOLOGIES INC |
H |
5 |
9 |
|
|
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
S9M |
H |
|
J |
U |
1 |
A |
$125.94 |
PG |
|
C2201X- |
Oct-01-2001 |
H |
| DF |
S9M |
H |
|
J |
U |
1 |
F |
$125.94 |
PG |
|
------- |
Oct-01-2001 |
H |
| DM |
S9M |
H |
Z |
J |
U |
1 |
M |
$125.94 |
PG |
|
1-M2--- |
Oct-01-2001 |
H |
| DN |
S9M |
H |
|
J |
U |
1 |
N |
$125.94 |
PG |
|
9L----- |
Oct-01-2001 |
H |
| DS |
S9M |
H |
|
J |
U |
1 |
D |
$125.94 |
PG |
|
------- |
Oct-01-2001 |
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DA |
K |
U/I CONTAINS 4EA |
000 |
|
|
|
| DA |
R |
REFER TO EDI ITEM |
000 |
|
|
|
| DF |
K |
U/I CONTAINS 4EA |
000 |
|
|
|
| DF |
R |
REFER TO EDI ITEM |
000 |
|
|
|
| DM |
K |
U/I CONTAINS 4EA |
000 |
|
|
|
| DN |
K |
U/I CONTAINS 4EA |
000 |
|
|
|
| DN |
R |
REFER TO EDI ITEM |
000 |
|
|
|
| DS |
K |
U/I CONTAINS 4EA |
000 |
|
|
|
| DS |
R |
REFER TO EDI ITEM |
000 |
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AGXZ |
UNIT PACKAGE TYPE |
PACKAGE |
| AJCN |
PROTECTIVE STORAGE FEATURE |
SUBJECT TO DAMAGE BY FREEZING AND REQUIRES REFRIGERATION BETWEEN 2 DEG TO 8 DEG C |
| ANNW |
IMMEDIATE CONTAINER TYPE |
VIAL, SINGLE DOSE |
| ANNX |
IMMEDIATE CONTAINER QUANTITY |
4 |
| ANNY |
QUANTITY WITHIN EACH IMMEDIATE CONTAINER |
0.5 ML |
| ECWT |
EXTERIOR CONTAINER WEIGHT |
10.00 POUNDS |
| EXME |
EXTERIOR CONTAINER CUBIC MEASURE |
0.04 CUBIC FEET |
| EXQT |
EXTERIOR CONTAINER QUANTITY |
100 |
| FEAT |
SPECIAL FEATURES |
EA VIAL CONTAINS 10 MCG PURIFIED HAEMOPHILUS B SACCHARIDE AND 25 MCG CRM197 PROTEIN; INTRAMUSCULAR ADMINISTRATION |
| SUCB |
UNIT OF ISSUE CUBE |
0.003 CUBIC FEET |
| SUWT |
UNIT OF ISSUE WEIGHT |
0.095 POUNDS |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| A111 |
|
Mar-10-2001 |
3 |
H |
|
|
|
|
| FSKX |
|
Mar-10-2001 |
3 |
H |
|
|
|
|
| MC15 |
|
Mar-10-2001 |
3 |
H |
|
|
|
|
| N9LM |
|
Mar-10-2001 |
3 |
H |
|
|
|
|
|